Cargando…

Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy

T helper 1 (Th1) type cytokines and chemokines are bioactive mediators in inflammation underling several diseases and co-morbid conditions, such as cardiovascular and metabolic disorders. Th1 chemokine CXCL10 participates in heart damage initiation/progression; cardioprotection has been recently ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Luigi, Luigi, Corinaldesi, Clarissa, Colletti, Marta, Scolletta, Sabino, Antinozzi, Cristina, Vannelli, Gabriella B., Giannetta, Elisa, Gianfrilli, Daniele, Isidori, Andrea M., Migliaccio, Silvia, Poerio, Noemi, Fraziano, Maurizio, Lenzi, Andrea, Crescioli, Clara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883282/ https://www.ncbi.nlm.nih.gov/pubmed/27165639 http://dx.doi.org/10.1007/s10753-016-0359-6

Ejemplares similares

The phosphodiesterase 5 inhibitor sildenafil decreases the proinflammatory chemokine IL-8 in diabetic cardiomyopathy: in vivo and in vitro evidence
por: Giannattasio, S., et al.
Publicado: (2018)

Vitamin D Receptor Agonists Target CXCL10: New Therapeutic Tools for Resolution of Inflammation
por: Scolletta, Sabino, et al.
Publicado: (2013)

Association of circulating CXCL10 and CXCL11 with systemic sclerosis
por: Crescioli, Clara, et al.
Publicado: (2018)

The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis
por: Colasanti, Tania, et al.
Publicado: (2022)

The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species
por: Di Luigi, Luigi, et al.
Publicado: (2020)

Muscle Damage in Systemic Sclerosis and CXCL10: The Potential Therapeutic Role of PDE5 Inhibition
por: Corinaldesi, Clarissa, et al.
Publicado: (2021)

Sildenafil Counteracts the In Vitro Activation of CXCL-9, CXCL-10 and CXCL-11/CXCR3 Axis Induced by Reactive Oxygen Species in Scleroderma Fibroblasts
por: Antinozzi, Cristina, et al.
Publicado: (2021)

Is chronic inhibition of phosphodiesterase type 5 cardioprotective and safe? A meta-analysis of randomized controlled trials
por: Giannetta, Elisa, et al.
Publicado: (2014)

Phosphodiesterase type 5 inhibitors: back and forward from cardiac indications
por: Corinaldesi, C., et al.
Publicado: (2015)

Testosterone insulin-like effects: an in vitro study on the short-term metabolic effects of testosterone in human skeletal muscle cells
por: Antinozzi, C., et al.
Publicado: (2017)

Vitamin D as a Shield against Aging
por: Fantini, Cristina, et al.
Publicado: (2023)

The Vitamin D Receptor Agonist BXL-01-0029 as a Potential New Pharmacological Tool for the Treatment of Inflammatory Myopathies
por: Di Luigi, Luigi, et al.
Publicado: (2013)

Advantages of Phosphodiesterase Type 5 Inhibitors in the Management of Glucose Metabolism Disorders: A Clinical and Translational Issue
por: Antinozzi, Cristina, et al.
Publicado: (2020)

Use of sildenafil or other phosphodiesterase inhibitors and risk of melanoma
por: Pottegård, Anton, et al.
Publicado: (2016)

Sildenafil, a cyclic GMP phosphodiesterase inhibitor, induces microglial modulation after focal ischemia in the neonatal mouse brain
por: Moretti, Raffaella, et al.
Publicado: (2016)

cAMP-specific phosphodiesterase 8A and 8B isoforms are differentially expressed in human testis and Leydig cell tumor
por: Campolo, Federica, et al.
Publicado: (2022)

OR21-6 Diabetic Cardiac Hypertrophy Is Associated With Viscoelastic Changes In Myocardial Contraction: Role Of Hsa-mir-122-5p On Extracellular Matrix.
por: Isidori, Andrea, et al.
Publicado: (2019)

Sildenafil Reduces Expression and Release of IL-6 and IL-8 Induced by Reactive Oxygen Species in Systemic Sclerosis Fibroblasts
por: Di Luigi, Luigi, et al.
Publicado: (2020)

Phosphodiesterases Expression during Murine Cardiac Development
por: Carvalho, Thays Maria da Conceição Silva, et al.
Publicado: (2021)

Extrathyroidal Calcitonin Secreting Tumors: Pancreatic Neuroendocrine Tumors in Patients With Multinodular Goiter: Two Case Reports
por: Giannetta, Elisa, et al.
Publicado: (2016)

Phosphodiesterase-5 inhibition preserves renal hemodynamics and function in mice with diabetic kidney disease by modulating miR-22 and BMP7
por: Pofi, Riccardo, et al.
Publicado: (2017)

Selenium Supplementation in Pregnant Women with Autoimmune Thyroiditis: A Practical Approach
por: Minnetti, Marianna, et al.
Publicado: (2022)

Phosphodiesterase Inhibitors Sildenafil and Vardenafil Reduce Zebrafish Rod Photoreceptor Outer Segment Shedding
por: Campbell, Leah J., et al.
Publicado: (2017)

Biphasic Effect of Sildenafil on Energy Sensing is Mediated by Phosphodiesterases 2 and 3 in Adipocytes and Hepatocytes
por: Banerjee, Jheelam, et al.
Publicado: (2019)

Chronic Inhibition of PDE5 Limits Pro-Inflammatory Monocyte-Macrophage Polarization in Streptozotocin-Induced Diabetic Mice
por: Venneri, Mary Anna, et al.
Publicado: (2015)

Management Strategies for Aggressive Cushing's Syndrome: From Macroadenomas to Ectopics
por: Pozza, Carlotta, et al.
Publicado: (2012)

Inhibition of Phosphodiesterase 3A by Cilostazol Dampens Proinflammatory Platelet Functions
por: Coenen, Daniëlle M., et al.
Publicado: (2021)

Sildenafil, a Phosphodiesterase Type 5 Inhibitor, Downregulates Osteopontin in Human Peripheral Blood Mononuclear Cells
por: Kaleta, Beata, et al.
Publicado: (2017)

Effect of the Phosphodiesterase 5 Inhibitor Sildenafil on Ischemia-Reperfusion-Induced Muscle Mitochondrial Dysfunction and Oxidative Stress
por: Tetsi, Liliane, et al.
Publicado: (2019)

Exosomes in Systemic Sclerosis: Messengers Between Immune, Vascular and Fibrotic Components?
por: Colletti, Marta, et al.
Publicado: (2019)

Needs and Expectations of Patients with Erectile Dysfunction: An Update on Pharmacological Innovations in Phosphodiesterase Type 5 Inhibition with Focus on Sildenafil
por: Jannini, Emmanuele A., et al.
Publicado: (2018)

Sildenafil, a phosphodiesterase-5 inhibitor, stimulates angiogenesis and bone regeneration in an atrophic non-union model in mice
por: Menger, Maximilian M., et al.
Publicado: (2023)

Phosphodiesterase 5 (PDE-5) inhibitors (sildenafil, tadalafil, and vardenafil) effects on esophageal motility: a systematic review
por: Shafiee, Arman, et al.
Publicado: (2023)

Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by (18)F-FDG PET/CT: A case report
por: Giannetta, Elisa, et al.
Publicado: (2017)

Serum Homocysteine Levels in Men with and without Erectile Dysfunction: A Systematic Review and Meta-Analysis
por: Sansone, Andrea, et al.
Publicado: (2018)

Sildenafil, a phosphodiesterase type 5 inhibitor, enhances the antidepressant activity of amitriptyline but not desipramine, in the forced swim test in mice
por: Socała, Katarzyna, et al.
Publicado: (2012)

Patient preference and satisfaction in erectile dysfunction therapy: a comparison of the three phosphodiesterase-5 inhibitors sildenafil, vardenafil and tadalafil
por: Raheem, Amr Abdel, et al.
Publicado: (2009)

The SIAMS-ED Trial: A National, Independent, Multicentre Study on Cardiometabolic and Hormonal Impairment of Men with Erectile Dysfunction Treated with Vardenafil
por: Isidori, Andrea M., et al.
Publicado: (2014)

Clinical, Diagnostic, and Therapeutic Aspects of Growth Hormone Deficiency During the Transition Period: Review of the Literature
por: Spaziani, Matteo, et al.
Publicado: (2021)

The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases
por: Nisini, Roberto, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v6n3h4jdre753np1a4ao7l8mro